As of Dec 09
| +0.0158 / +2.38%|
The 3 analysts offering 12-month price forecasts for Xtant Medical Holdings Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +414.71% increase from the last price of 0.68.
The current consensus among 3 polled investment analysts is to Buy stock in Xtant Medical Holdings Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.